Clin2
NCT06409832Possibly a fitRecruiting

Study of rimegepant for migraine prevention

MigraineMigraine With AuraMigraine Without Aura

Treatments studied

Part of Brain & nervous system, Pain clinical trials.

This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a diagnosis of migraine (with or without aura) from your doctor.
  • You have at least 4 migraine days per month on average.
  • You are able to keep a headache diary and follow study instructions.
  • You do not have chronic migraine (15+ headache days per month).
  • You are not pregnant or breastfeeding.
  • You have not changed your migraine prevention medicine in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05903027Recruiting
Testing gepant migraine treatment for better side effects

This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.

Florence
NCT06728345Not yet recruiting
Rimegepant for preventing migraines in women

This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.

NCT07301008Recruiting· Phase 4
Rimegepant to prevent predictable trigger-induced migraines

This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.

McLean, Virginia
NCT05156398Recruiting· Phase 3
Rimegepant to prevent migraine attacks in children

This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.

Fort Smith, Arkansas
NCT07832032Not yet recruiting
Blood study of migraine markers

This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.

Bodø
NCT07667621Not yet recruiting· Phase 1
Migraine medicines in the emergency department

This trial tests whether a new class of migraine medicines, called gepants, can relieve migraine pain quickly when given in the emergency department. If you're having a migraine and haven't taken pain medication recently, you might be able to join.

Tampa, Florida

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.